FDA has announced a new guidance for labeling of reprocessed medical devices and validation of the reprocessing procedure, a guidance that supplants its predecessor from 1996. One obvious difference in the new requirement is that labels will have to comply with requirements addressing human factors engineering, which has been the subject of much emphasis of late. (Medical Device Daily) Read More
